CRF Health extends innovation team with industry pioneer

Bill Byrom

CRF Health, provider of patient-centered eSource technology and service solutions for the life sciences industry, announced the appointment of Bill Byrom as VP of Product Strategy and Innovation.

Byrom, who brings more than two decades of pioneering industry experience to CRF Health, will help leverage the company’s growing solution portfolio including the Internet of Medical Things (IoMT).

In his 27-year career, Byrom has served in leadership and advisory roles for notable global pharma influencers, including Knoll, Boots and Zeneca, and latterly with eClinical technology providers and service leaders, ClinPhone Group and Perceptive Informatics.

He is renowned as a thought-leader and pioneer in strategy, development and operationalisation of clinical trials technologies including mobile, wearable and electronic patient reported outcomes solutions. Most recently, he was Senior Director of Product Innovation with ICON Clinical Research, responsible for driving direct-to-patient trial strategy and solution development.

Byrom also serves as Vice Director of Critical Path Institutes’ ePRO Consortium, leads a DIA working group on the development of clinical trial endpoints derived from wearables data and is a guest lecturer on innovation strategy within the MSc Business programme at a leading UK University.

Speaking on the appointment, CRF Health’s CEO, Rachael Wyllie, said: “We are delighted to welcome Bill Byrom to the CRF Health team. Bill is an outstanding strategist and his expertise and experience will ensure that our work continues to be delivered with the absolute highest standards. He will be an invaluable addition to the team, advancing our mission to improve the quality of patients’ lives by delivering the most accurate and comprehensive picture of patient health.”

Byrom added: “I am looking forward to joining the team. CRF Health has a clear and exciting vision for the future and the market opportunity in direct to patient eClinical technology and solution development is undeniable. I am excited to see what we can achieve together.”